Alder BioPharmaceuticals is a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics for the treatment of migraine, Cushing’s disease, Congenital Adrenal Hyperplasia and autoimmune and inflammatory diseases.

ALD403

ALD403 and Migraine

Newswire

ClinicalTrials

Current trials
Menu
×